-
今开：--
昨收：--
-
今日区间：--
52周区间：--
-
成交量：--
成交额：--
-
市 值：--
市盈率：--
-
振幅：
每股收益：
成交量
公司高管
- David A. Ricks
- David A. Ricks is currently Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is also Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. Since 2018, he has been an Independent Director at Adobe, Inc. He is a Director at Pharmaceutical Research & Manufacturers of America since 2022 and at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former positions include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
-
- Nathaniel R. Miles
- Nathaniel R. Miles is currently the Chairman of Urban League of Metropolitan Seattle. He also holds the position of Director at Hightowers Petroleum Co., University of Washington Foundation, Alliance for Education, Association of Washington Business, Eli Lilly & Co., and National Association for the Advancement of Colored People. In the past, Mr. Miles has worked as a Director at Medical Teams International, Centerstone of Indiana, Inc., Washington State Convention & Trade Center, Boys & Girls Clubs of King County, Overlake Hospital Foundation, and Puget Sound Regional Council. Mr. Miles completed his undergraduate degree at the University of Washington.
-
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
- David A. Ricks
- David A. Ricks is currently Chairman, President & Chief Executive Officer at Eli Lilly & Co. since 2017. He is also Chairman & Chief Executive Officer at Eli Lilly & Co. Ltd. and Eli Lilly Italia SpA. He serves as Chairman-Governors Board at James Whitcomb Riley Children's Foundation. Since 2018, he has been an Independent Director at Adobe, Inc. He is a Director at Pharmaceutical Research & Manufacturers of America since 2022 and at The Central Indiana Corporate Partnership. He is a Member of The Business Roundtable and The Business Council. Former positions include Director at European Federation of Pharmaceutical Industries & Assns, Director at Elanco Animal Health, Inc. from 2018 to 2019, Principal at HP, Inc., Principal at International Business Machines Corp., President at International Federation of Pharmaceutical Manufacturers, President at Lilly USA LLC from 2009 to 2012, President & General Manager at Lilly Industries Shanghai Ltd. in 2009, and General Manager at Eli Lilly Canada, Inc. from 2005 to 2008. Education includes an MBA from Indiana University in 1996 and an undergraduate degree from Purdue University in 1990.
-
- Donald A. Zakrowski
- Donald A. Zakrowski is currently the Chief Accounting Officer & Vice President-Finance at Eli Lilly & Co. He previously worked as a Senior Manager at PricewaterhouseCoopers LLP.
-
旧服务已下线，请迁移至 http://api.fanyi.baidu.com
- Robert J. Heine
- Robert J. Heine has a current job as the Vice President-Medical Affairs at Eli Lilly & Co.
-
- Daniel M. Skovronsky
- Daniel M. Skovronsky was the founder of Avid Radiopharmaceuticals, Inc., founded in 2004, where the title held was Chief Executive Officer. Current jobs include Independent Director at Myriad Genetics, Inc. since 2020; Chief Scientific Officer & Executive Vice President at Eli Lilly & Co. starting in 2024; Member at the University of Pennsylvania; Member-Governance Board at Indianapolis Museum of Art, Inc.; and President, Chief Scientific Officer & Senior Vice President at Lilly Research Laboratories since 2018. Education history includes a doctorate from the University of Pennsylvania conferred in 2000, an undergraduate degree from Yale University conferred in 1994, and a doctorate from Perelman School of Medicine conferred in 2001.
-
- Lucas E. Montarce
- Mr. Lucas E. Montarce is a Chief Financial Officer, Group VP & Controller at Lilly Research Laboratories and a Chief Financial Officer & Executive Vice President at Eli Lilly & Co. He is on the Board of Directors at Christel House International, Inc. Mr. Montarce was previously employed as a Vice President by Elanco Animal Health, Inc. He received his undergraduate degree from The Catholic University of America and an MBA from Universidad del CEMA.
-
- Robert Conley
- Robert Conley has worked at Eli Lilly & Co. since 2017 as a Development Leader-Neuroscience.
-
- Anat Hakim
- Anat Hakim is currently working as a Secretary, Executive VP & General Counsel at Eli Lilly & Co. Prior to this, Anat worked at WellCare Health Plans, Inc. as a Secretary, Executive VP & General Counsel from 2018 to 2020. Anat also worked at Abbott Laboratories as a Divisional VP & Associate General Counsel from 2010 to 2016. Before that, Anat was an Equity Partner at Foley & Lardner LLP from 1998 to 2010 and an Associate at Latham & Watkins LLP from 1993 to 1997. Anat completed their undergraduate degree at the University of Wisconsin in 1990 and their graduate degree at Harvard Law School in 1993.
-
- Patrik Jonsson
- Patrik Jonsson currently works at Eli Lilly & Co., as Executive VP & President-Lilly International from 2025. Mr. Jonsson also formerly worked at The American Chamber of Commerce in Japan, as Director, Eli Lilly Italia SpA, as President & General Manager, and Lilly USA LLC, as President. Mr. Jonsson received his undergraduate degree from Lund University School of Economics & Management.
-
- Ilya Yuffa
- Ilya Yuffa currently works at European Federation of Pharmaceutical Industries & Assns, as Director, The U.S.-Japan Business Council, Inc., as Director, Eli Lilly & Co., as Executive VP- Global Customer Capabilities from 2025, and Lilly USA LLC, as President from 2025. Mr. Yuffa also formerly worked at Farmindustria, as Director. Mr. Yuffa received his undergraduate degree in 1996 from Tulane University (Louisiana) and Masters Business Admin degree in 2002 from London Business School.
-
- Edgardo Hernandez
- Edgardo Hernandez is currently working as the President-Manufacturing Operations & Senior VP at Eli Lilly & Co. He started this position in 2021. Prior to his current role, he obtained a graduate degree from North Carolina State University and an undergraduate degree from the University of Puerto Rico.
-
- Diogo Rau
- Diogo Rau is the founder of GiftGateway. He is currently working as the Executive VP, Chief Information & Digital Officer at Eli Lilly & Co. Prior to this, he held the position of Senior Director-Information Systems & Technology at Apple, Inc. and was a Partner at McKinsey & Co., Inc. Mr. Rau completed his undergraduate and graduate degrees at Stanford University.
-
- Christian Nguyen
- Christian Nguyen has worked as a Director at the National Pharmaceutical Council since 2021 and holds the position of VP-Global Patient Outcomes & Real World Evidence at Eli Lilly & Co.
-
- Andy Vicari
- Andy Vicari currently works at Eli Lilly & Co., as Senior Director & US Brand Leader-Insulins and American Diabetes Association, as Member-Indiana Community Leadership Board.
-
- Kim Macko
- Eli Lilly & Co.'s Head-Global Brand Development is currently held by Kim Macko.
-
- Eric Dozier
- Eric Dozier currently works at Christian Theological Seminary, Inc., as Director, Center for Leadership Development, Inc., as Director, Indianapolis Airport Authority (Indiana), as Director, and Eli Lilly & Co., as Chief People Officer & Executive Vice President from 1998. Mr. Dozier received his Masters Business Admin degree from Indiana University and undergraduate degree from The Ohio State University.
-
- Laura A. Lane
- Laura A. Lane was the founder of Virion Biotherapeutics Ltd. which was founded in 2015, where she held the title of Chief Operating Officer & Director from 2015 to 2018. Currently, she is a Vice President at Eli Lilly & Co. since 2022. Previously, she worked as a Principal at Advent Venture Partners LLP from 2019 to 2022. Ms. Lane received her undergraduate and doctorate degrees from the University of Cambridge.
-
- Ruth Gimeno
- Ruth Gimeno has held positions at BioCrossroads as a Board of Director and at Eli Lilly & Co. as Vice President. Both roles are current.
-
- Mark Genovese
- Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University. From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.
-
- David Hyman
- David Hyman has worked as a Chief Medical Officer at Eli Lilly & Co. since 2023 and at Loxo Oncology, Inc. since 2020.
-
- Jennifer Oleksiw
- Jennifer Oleksiw currently works at Eli Lilly & Co., as Global Chief Customer Officer & Vice President from 2023.
-
- Joe Fletcher
- Joe Fletcher currently works at Eli Lilly & Co., as Investor Relations Contact.
-
- Jacob S. van Naarden
- Jacob S. van Naarden is Chief Executive Officer at Loxo Oncology, Inc. since 2014. He is Director at Delfi Diagnostics, Inc. since 2022. He is President-Lilly Oncology & Executive Vice President at Eli Lilly & Co. since 2024. Formerly, Mr. van Naarden was an Analyst at HealthCor Management LP from 2013 to 2014. He was an Associate at Aisling Capital LLC from 2008 to 2013. He worked as an Analyst at Goldman Sachs & Co. LLC from 2006 to 2008. Mr. van Naarden completed undergraduate studies at Princeton University in 2006.
-
- Melissa Seymour
- Melissa Seymour is currently Chairman at Parenteral Drug Association since 2026 and Executive Vice President-Global Quality at Eli Lilly & Co. since 2024. Formerly, Ms. Seymour was Chief Quality Officer at Bristol Myers Squibb Co. Education includes an MBA from Duke University and an undergraduate degree from North Carolina State University.
-
- Thomas Fuchs
- Thomas Fuchs currently works at GeneDx Holdings Corp., as Director from 2025 and Eli Lilly & Co., as Chief Artificial Intelligence Officer & Senior VP. Dr. Fuchs received his doctorate degree from Swiss Federal Institute of Technology and graduate degree from Graz University of Technology.
-
- Carole Ho
- Dr. Carole Ho, MD, is an Executive VP & President-Lilly Neuroscience at Eli Lilly & Co. and an Independent Director at Royalty Pharma Plc. She is on the Board of Directors at Royalty Pharma Plc. Dr. Ho was previously employed as an Independent Director by NGM Biopharmaceuticals, Inc., an Independent Director by Beam Therapeutics, Inc., a Chief Medical Officer & Head-Development by Denali Therapeutics, Inc., a VP-Non Oncology Early Clinical Development by Genentech, Inc., a Medical Director by Johnson & Johnson, and a Chief Resident-Neurology by The General Hospital Corp. She received her undergraduate degree from Harvard College and a doctorate degree from Weill Cornell Medicine.
-